Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Bullboard - Stock Discussion Forum Emerald Health Therapeutics Inc EMHTF

Emerald is committed to creating new consumer experiences with distinct recreational, medical and wellness-oriented cannabis products with an emphasis on innovation and production excellence.

OTCQB:EMHTF - Post Discussion

Emerald Health Therapeutics Inc > Chris Wagner gone. Phew...Thank Goodness!
View:
Post by cannhealth on Nov 28, 2018 12:43pm

Chris Wagner gone. Phew...Thank Goodness!

I never liked Mr Wagner. His public speaking skills were barely adequate at best and at worst.. embarrassing. To me he appeared burnt-out, so I'm relieved he's gone. As for Mr Dilman's departure.. C'est la vie. I'm unsure what he accomplished while he was with EMH, though it doesn't seem like much. I'm all for eliminating two very highly paid persons from the payroll as I've never believed "executive" level staff truly earn their huge salaries and bonuses. In my experience, it's the rank and file sales people who do all the heavy lifting when it comes to the bulk of a company's revenue.
Comment by goal111 on Nov 28, 2018 2:29pm
you already said what i wanted to say. Lets hope Mr. Dhillon has a great vision for the company and does well for the shareholders as he himself has a big chunk of his money invested here too. GLTA
Comment by cannhealth on Nov 28, 2018 4:21pm
Yes Dubbs. I'm sure we're not the only investors pleased to hear the door slamming against the a$$es of Mr Wagner and Dilman on their way out. In fact, the only tangible impact I've seen on the company's revenue by Mr Dilman has been him exercising his 420K options given when he was hired. Obviously Avtar had an issue with their performance / contribution with / to the company' ...more  
The Market Update
{{currentVideo.title}} {{currentVideo.relativeTime}}
< Previous bulletin
Next bulletin >

At the Bell logo
A daily snapshot of everything
from market open to close.

{{currentVideo.companyName}}
{{currentVideo.intervieweeName}}{{currentVideo.intervieweeTitle}}
< Previous
Next >
Dealroom for high-potential pre-IPO opportunities